DiaSys at the Pharma Forum 2022

The Pharma Forum is organized annually by the Association of Research-Based Pharmaceutical Companies (vfa), the Health Policy Working Group “Mitte” as a regional interest group of research-based pharmaceutical companies, the Ministries of Economics of Hesse and Rhineland-Palatinate and the State Chancellery of Saarland.

Since the awarding of the 2021 Innovation Prize, DiaSys is remembered as an innovative company of the medical device industry to the Ministry of Economics of Rhineland-Palatine. DiaSys gratefully accepted a corresponding invitation to participate in the Pharma Forum as an exhibitor and scientific player. This year, the theme of the event was "Medicine according to Corona - New technologies for the healthcare industry".

In the rubric "Pacesetters for Health: Innovations from Europe for the World", R&D Director Prof. Dr. Matthias Grimmler gave a lecture on the topic "When Every Hour Counts: Modern diagnostics for a globally effective and reliable sepsis management". The participants got an impressive presentation on how crucial the correct and rapid diagnosis of sepsis is for a patient's chances of survival.

His presentation highlighted the availability of Procalcitonin FS since February 2020, an assay that can quickly and efficiently determine procalcitonin, the most important marker of sepsis, on any common analyzer worldwide. In addition, the scientifically proven link between Covid-19 and sepsis was emphasized during the presentation.

Represented by Thomas Blameuser, DiaSys Deutschland Vertriebs-GmbH provided supporting information material for all interested parties at the DiaSys booth. Procalcitonin FS was presented to a broad audience on this day and successfully aroused the interest of potential new business partners.

An all-around successful event and a good opportunity to present the innovative power of DiaSys Diagnostic Systems GmbH.